Cascadian Therapeutics (FRA:3O61) Beta : N/A (As of May. 03, 2024)

Cascadian Therapeutics Beta Chart

Cascadian Therapeutics Annual Data
	Trend	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
Beta		Get a 7-Day Free Trial					0.51	1.94	1.24	1.79	1.71

Cascadian Therapeutics Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17
Beta	Get a 7-Day Free Trial															1.79	1.13	1.42	1.59	1.71

Competitive Comparison of Cascadian Therapeutics's Beta

For the Biotechnology subindustry, Cascadian Therapeutics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cascadian Therapeutics's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cascadian Therapeutics's Beta distribution charts can be found below:

* The bar in red indicates where Cascadian Therapeutics's Beta falls into.

Cascadian Therapeutics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Cascadian Therapeutics  (FRA:3O61) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Cascadian Therapeutics Beta Related Terms

Thank you for viewing the detailed overview of Cascadian Therapeutics's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

Cascadian Therapeutics (FRA:3O61) Business Description